FemPulse™, a bioelectronic medical technology company with first application overactive bladder, announced today that an ...
TScan Therapeutics announced an accepted abstract for poster presentation at ASGCT's annual meeting on TCR-engineered therapies for cancer. TScan Therapeutics, Inc., a clinical-stage biotechnology ...
BERKELEY HEIGHTS, N.J., Dec. 06, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and ...
Clarity Pharmaceuticals (ASX: CU6), a clinical-stage radiopharmaceutical company focused on developing next-generation ...
There are many venues in which to present your research findings, both within BCM and at external conferences. Your research mentor is likely to be an excellent source of information regarding ...
FOSTER CITY, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (TERN), a clinical stage oncology company, today announced that data from the ongoing CARDINAL trial of TERN-701, a ...
Clarity Pharmaceuticals (ASX: CU6) (Clarity or Company), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback